Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

FDA Panel To Consider Antimicrobial Effectiveness, Classifications Of Wound Dressings

Executive Summary

In light of recent advances in wound-care technology, US FDA is asking its General and Plastic Surgery Devices advisory panel to discuss indications for use, and safety and effectiveness of the latest drug-containing wound dressings, as well as antimicrobial effectiveness of dressings, at a Sept. 20-21 meeting.


Related Content

FDA Panel Supports Class II For Wound Dressings, But More Controls When Antibiotics Are Added





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst